Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

15 January 2002

Extended-spectrum beta-lactamase-producing Enterobacteriaceae strains in community-acquiredbacteremia in Southern Israel.

Nechama Peled, Jacob Gilad, Galia Menashe, Abraham Borer, Klaris Riesenberg, Francisc Schlaeffer

Med Sci Monit 2002; 8(1): CR44-47 :: ID: 420952

Abstract

BACKGROUND: In recent years, extended-spectrum beta-lactamase (ESBL)-producingEnterobacteriaceae have emerged in many hospitals worldwide. The increasing dissemination and long-termcarriage of these organisms within the community carry tremendous implications on the empirical therapyof community-acquired infection. MATERIAL/METHODS: To evaluate the prevalence and clinical features ofcommunity-acquired bacteremia involving ESBL-producing Enterobacteriaceae in southern Israel (ESBL-P)we retrospectively studied all Enterobacteriaceae bacteremias during an 8-month period in the Negev regionusing medical and laboratory records. Antibiotic susceptibility was determined using the disk-diffusionmethod. ESBL production was determined using an E-test ESBL strip. Cases involving ESBL-P were comparedto those involving non-producing strains (ESBL-NP) using the chi-square test. RESULTS: In all, 187 Enterobacteriaceaebacteremias were detected, of which 119 were community-acquired (63.6%). ESBL-P were found in six cases(5%) which are described herein in greater detail. Patients with ESBL-P bacteremia were older, and weremore likely to stay in the intensive-care unit. Urinary catheterization and bed-ridden conditions weresignificant risk factors for ESBL-P. ESBL-P strains were significantly resistant to nearly all antibioticagents except for imipienem and piperacillin-tazobactam as opposing to ESBL-NP. Patients with ESBL-Pbacteremia were more likely to suffer from complications and had a higher mortality. CONCLUSIONS: Thispaper is the first to describe community-acquired Enterobacteriaceae bacteremia involving ESBL-P strainsin Israel. Although the exact prevalence of these organisms in Israel is currently unknown, our findingssuggest that ESBL-producers have already begun to disseminate in our community.

Keywords: Aged, 80 and over, Community-Acquired Infections, Enterobacteriaceae, Enterobacteriaceae Infections, Israel, beta-Lactamases

Add Comment 0 Comments

Editorial

01 May 2024 : Editorial  

Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)

Dinah V. Parums

DOI: 10.12659/MSM.944927

Med Sci Monit 2024; 30:e944927

In Press

07 May 2024 : Clinical Research  

Treatment of AVN-Induced Proximal Pole Scaphoid Nonunion Using a Fifth and Fourth Extensor Compartmental Ar...

Med Sci Monit In Press; DOI: 10.12659/MSM.944553  

16 Mar 2024 : Clinical Research  

Diagnostic Efficiency of ACR-TIRADS Score for Differentiating Benign and Malignant Thyroid Nodules of Vario...

Med Sci Monit In Press; DOI: 10.12659/MSM.943228  

08 May 2024 : Clinical Research  

Effect of Individualized PEEP Guided by Driving Pressure on Diaphragm Function in Patients Undergoing Lapar...

Med Sci Monit In Press; DOI: 10.12659/MSM.944022  

21 Mar 2024 : Clinical Research  

Impact of Serum Vitamin D, B6, and B12 and Cognitive Functions on Quality of Life in Peri- and Postmenopaus...

Med Sci Monit In Press; DOI: 10.12659/MSM.943249  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750